Voyageur Pharmaceuticals Ltd.
VYYRF
$0.12
$0.002.22%
OTC PK
| 05/31/2026 | 02/28/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -16.31% | 2,720.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -16.31% | 2,720.00% | |||
| Cost of Revenue | -16.31% | 981.25% | |||
| Gross Profit | -- | -100.00% | |||
| SG&A Expenses | 46.00% | -23.87% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 44.00% | -21.14% | |||
| Operating Income | -45.97% | 23.59% | |||
| Income Before Tax | -57.18% | 25.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -57.18% | 25.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -57.18% | 25.83% | |||
| EBIT | -45.97% | 23.59% | |||
| EBITDA | -46.00% | 23.60% | |||
| EPS Basic | -53.85% | 25.71% | |||
| Normalized Basic EPS | -56.25% | 27.27% | |||
| EPS Diluted | -53.85% | 25.71% | |||
| Normalized Diluted EPS | -56.25% | 27.27% | |||
| Average Basic Shares Outstanding | 0.24% | 0.12% | |||
| Average Diluted Shares Outstanding | 0.24% | 0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||